Bio-Rad
For over six decades, Bio-Rad has served life science research and clinical diagnostics customers worldwide through its global network of operations. Bio-Rad is internationally renowned among academic institutions, pharmaceutical companies and major research institutions for its commitment to quality and customer service.
Latest Bio-Rad Content
Product News
Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalized monitoring of solid tumor cancers with droplet digital PCR
Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.
Product News
Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection
Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.
Product News
Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production
Rapid, sensitive, and validated detection of viral replication genes using droplet digital™ PCR during cell and gene therapy production.
Ask Me Anything
Ask Me Anything: Cell-to-Cell Communication in Cancer
On-Demand
Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.
Online Event
Cell and Gene Therapy 2024
On-Demand
Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.
Industry Insight
Increasing Widespread Accessibility of Molecular Testing for Oncology Research
Bio-Rad's Jeremiah McDole explores the benefits of bringing molecular testing in-house and how ddPCR technology can be applied in oncology workflows.
Webinar
The Latest in Flow Cytometry – The Rise of the 488 nm Laser
On-Demand
This webinar will give you a brief understanding of the history of flow cytometry and how the 488 nm blue laser has played a crucial role in making flow cytometry a key application in research.
Whitepaper
Illuminating Immunology With Spectral Flow Cytometry
Flow cytometry is a core technique in many immunology labs.. However, extensive immunophenotyping panels can result in overlapping emission peaks, time-consuming compensation and complex data analysis.
Product News
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.
App Note / Case Study
The Latest ddPCR Technology for Mutation Detection Multiplexing
This app note highlights the latest ddPCRTM solutions for advanced assay multiplexing. It demonstrates how researchers can get the most out of precious clinical samples, with time and cost-saving advantages over gene sequencing methods.
Advertisement
